Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

May 01, 1986; Volume 29,Issue 5
  • You have access
    The binding of L-[3H]nicotine to a single class of high affinity sites in rat brain membranes.
    P M Lippiello and K G Fernandes
    Molecular Pharmacology May 1986, 29 (5) 448-454;
  • You have access
    Identification of the phosphodiesterase regulated by muscarinic cholinergic receptors of 1321N1 human astrocytoma cells.
    L I Tanner, T K Harden, J N Wells and M W Martin
    Molecular Pharmacology May 1986, 29 (5) 455-460;
  • You have access
    Forskolin enhances calcium-evoked prolactin release from 7315c tumor cells without increasing the cytosolic calcium concentration.
    E A Frey, J W Kebabian and S Guild
    Molecular Pharmacology May 1986, 29 (5) 461-466;
  • You have access
    The interaction between the activator agents batrachotoxin and veratridine and the gating processes of neuronal sodium channels.
    T A Rando, G K Wang and G R Strichartz
    Molecular Pharmacology May 1986, 29 (5) 467-477;
  • You have access
    Effect of N-hydroxyparacetamol on DNA, RNA, and protein synthesis and chromatin structure.
    N K Hayward, I Calder and M F Lavin
    Molecular Pharmacology May 1986, 29 (5) 478-483;
  • You have access
    Paraquat uptake into freshly isolated rabbit lung epithelial cells and its reduction to the paraquat radical under anaerobic conditions.
    J K Horton, R Brigelius, R P Mason and J R Bend
    Molecular Pharmacology May 1986, 29 (5) 484-488;
  • You have access
    Neurotensin-mediated inhibition of cyclic AMP formation in neuroblastoma N1E115 cells: involvement of the inhibitory GTP-binding component of adenylate cyclase.
    J C Bozou, S Amar, J P Vincent and P Kitabgi
    Molecular Pharmacology May 1986, 29 (5) 489-496;
  • You have access
    gamma-Aminobutyric acid agonists and antagonists alter chloride flux across brain membranes.
    A M Allan and R A Harris
    Molecular Pharmacology May 1986, 29 (5) 497-505;
  • You have access
    Isolation and characterization of bovine cardiac muscle cGMP-inhibited phosphodiesterase: a receptor for new cardiotonic drugs.
    S A Harrison, D H Reifsnyder, B Gallis, G G Cadd and J A Beavo
    Molecular Pharmacology May 1986, 29 (5) 506-514;
  • You have access
    Structural and functional characterization of guanyl nucleotide-binding proteins using monoclonal antibodies to the alpha-subunit of transducin.
    J L Halpern, S C Tsai, R Adamik, Y Kanaho, E Bekesi, H F Kung, J Moss and M Vaughan
    Molecular Pharmacology May 1986, 29 (5) 515-519;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 29, Issue 5
1 May 1986
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics